Association of Acetaminophen Exposure with Increased Risk of Eczema in Children: A Meta-Analysis
Dongqiong Xiao,Xiaojuan Su,Yi Qu,Yan Zhou,Lingli Pan,Xihong Li,Dezhi Mu
DOI: https://doi.org/10.1016/j.jaad.2019.04.017
IF: 15.487
2019-01-01
Journal of the American Academy of Dermatology
Abstract:To the Editor: Many studies1Fazlollahi M.R. Abbasi J.M. Dana V.G. Yousefzade A. Sabetkish N. Haghighat S. Evaluation of allergic symptoms prevalence and its relationship with acetaminophen/antibiotic use and hospitalization among school-aged children in Tehran, Iran.Iran Red Crescent Med J. 2017; 19: e45724Google Scholar, 2Suarez-Medina R. Venero-Fernandez S.J. de la Mora-Faife E. et al.Risk factors for eczema in infants born in Cuba: a population-based cross-sectional study.BMC Dermatol. 2014; 14: 6Google Scholar, 3Wang J.-Y. Liu L.-F. Chen C.-Y. Huang Y.-W. Hsiung C.A. Tsai H.-J. Acetaminophen and/or antibiotic use in early life and the development of childhood allergic diseases.Int J Epidemiol. 2013; 42: 1087-1099Google Scholar, 4Beasley R.W. Clayton T.O. Crane J. et al.Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents international study of asthma and allergies in childhood phase three.Am J Respir Crit Care Med. 2011; 183: 171-178Google Scholar, 5Cohet C. Cheng S. MacDonald C. et al.Infections, medication use, and the prevalence of symptoms of asthma, rhinitis, and eczema in childhood.J Epidemiol Community Health. 2004; 58: 852-857Google Scholar have assessed the relationship between acetaminophen exposure and the risk of development of eczema (atopic dermatitis) in children. However, the results remain controversial. Here we report a meta-analysis to evaluate the potential association between acetaminophen exposure and the risk of development of eczema in children. We used the EMBASE, PubMed, and Cochrane Library databases to conduct a meta-analysis of studies published before September 29, 2018, and written in English. The search for studies related to acetaminophen was performed by using the key words and subject terms: acetaminophen, paracetamol, Panadol, and Tylenol, using OR to link the relevant text within the search field. To acquire studies related to eczema, OR was used to associate the key words, which included dermatitis, eczema, neurodermatitis, and dermatitis, atopic. We combined these terms using AND to retrieve the relevant studies. Animal studies, studies with adult participants, reports with no indication of the association between acetaminophen and eczema, duplicated reports, case reports, reviews, and meta-analyses were excluded. Two reviewers (D.X. and X.S.) performed data extraction, evaluated the methodologic quality of the included reports with the Newcastle-Ottawa scale, and discussed disagreements to reach a consensus. The literature search yielded 314 reports. In total, 15 reports with 901,875 participants were included (see https://data.mendeley.com/datasets/kjbx2v3w6z/1/files/958a9e46-adbc-42c2-92c5-1e9876aa960a/Table%201%20of%20Research%20letter%20of%20JAAD.docx?dl=1). According to the random effects model, acetaminophen exposure increased the risk of eczema (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.23-1.62; P < .05) in children. Children exposed prenatally to acetaminophen did not seem to have increased risk of eczema (OR, 1.31; 95% CI, 0.97-1.76; P > .05), and children exposed to acetaminophen during the most recent year seemed to have the greatest risk of eczema (OR, 1.70; 95% CI, 1.50-1.92; P < .05). In addition, children exposed to acetaminophen in early life seemed to have increased risk of eczema (OR, 1.21; 95% CI, 1.04-1.40; P < .05). We conducted separate stratified analyses based on study location (single country or multiple countries), study design (cohort study or cross-sectional study), sample size (<10,000 or ≥10,000), acetaminophen exposure at different doses and frequencies (once per year, at least once per month, or other), eczema diagnosed at different patient ages (age, <3 years, 3-7 years, or >7 to 18 years), and whether the study controlled for potential confounders (unadjusted estimates or adjusted estimates) (Table I). Factors explaining differences in the study included sample size, different dosages and durations of acetaminophen use, different patient ages at the diagnosis of eczema, and whether the studies adjusted for potential confounders (Table I).Table IResults of stratified analysis of the association between acetaminophen exposure and the risk of eczema in childrenVariablePrenatal acetaminophen exposureP valueAcetaminophen exposure in early life (age, ≤1 y)P valueAcetaminophen exposure during the most recent year (age, >1 y)P valueStudiesOR (95% CI)I2 (P value)StudiesOR (95% CI)I2 (P value)StudiesOR (95% CI)I2 (P value)Total31.31 (0.97-1.76)0 (.37)>.0581.21 (1.04-1.40)0.84 (.0581.65 (1.37-1.98)0.84 (.05 Cross-sectional0NANA0NANA31.60 (1.22-2.10)0.82 (.003)Acetaminophen exposure at different dosage and frequency Once/y0NANA>.0521.19 (1.10-1.28)0 (.71).0531.18 (1.04-1.34)0.62 (.07)7 to 18 y0NANA12.05 (1.61-2.61)NA41.84 (1.73-1.95)0.75 (.0531.31 (1.23-1.39)0.67 (.05)>.0551.57 (1.41-1.74)0.69 (.01)